Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by HARLE, D. G.
Right arrow Articles by FISHER, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HARLE, D. G.
Right arrow Articles by FISHER, M. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1985, Vol. 57, No. 11 1073-1076
© 1985 The Board of Management and Trustees of the British Journal of Anaesthesia


research-article

CROSS-REACTIVITY OF METOCURINE, ATRACURIUM, VECURONIUM AND FAZADINIUM WITH IgE ANTIBODIES FROM PATIENTS UNEXPOSED TO THESE DRUGS BUT ALLERGIC TO OTHER MYONEURAL BLOCKING DRUGS

D. G. HARLE, B.Sc,(HONS), B. A BALDO, PH.D and M. M. FISHER, F.F.A.R.A.C.S.

Kolling Institute of Medical Research
Department of Medicine, University of Sydney, Sydney, Australia.
Intensive Therapy Unit, Royal North Shore Hospital of Sydney, St Leonards, N.S.W., 2065

1Correspondence to M.M.F., Intensive Therapy.Unit, Royal North Shore Hospital.

An inhibition assay was used to determine quantitatively the allergenic cross-reactivity of some myoneural blocking drugs not yet released for use in Australia, in the sera of patients who had experienced anaphylactic reactions to neuromuscular blocking drugs. Two of the compounds, metocurine and atracurium were highly cross-reactive with the currently used myoneural blockers; fazadinium was weakly cross-reactive and vecuronium intermediate in potency between these two extremes. From these results, we predict that anaphylactic reactions to these compounds, and particularly to metocurine and atracurium, will occur in some patients allergic to the currently used neuromuscular blocking agents.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
D. L. Hepner and M. C. Castells
Latex Allergy: An Update
Anesth. Analg., April 1, 2003; 96(4): 1219 - 1229.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.